ASTRAZEN — Astrazeneca Pharma India Share News
0.000.00%
Last trade - 00:00- IN₹210.84bn
- IN₹207.37bn
- IN₹22.76bn
European shares near record high following robust earnings; BoE rate decision awaited
AstraZeneca shareholders say they need clarity on China investigations
UK Stocks-Factors to watch on Feb 4 (updated)
AstraZeneca ditches plan to build $558 mln UK vaccine plant (updated)
Brief: Astrazeneca Pharma India Gets Order From Transfer Pricing Officer
Astrazeneca Pharma India jumps 8% after job cuts in biopharma unit
Brief: Astrazeneca Pharma India Confirms Restructuring Of Biopharmaceutical Team
Media: AstraZeneca India recasts biopharma unit - ET
Brief: Astrazeneca Pharma India Gets Permission To Import For Sale And Distribution Of Lynparza
Brief: Astrazeneca Pharma India Will Launch Breztri Aerosphere In January 2025 In India
Astrazeneca Pharma India slips on Q2 profit drop
Brief: Astrazeneca Pharma India Sept-Quarter PAT 384.3 Mln Rupees
Brief: Astrazeneca Pharma India Says Shipla Divekar Nirula Unanimously Elected As Chairperson
AstraZeneca Pharma India gains on import nod for cancer drug
Brief: Astrazeneca Pharma India Gets Permission To Import Durvalumab
Brief: Astrazeneca Pharma India To Launch Tremelimumab (Imjudo) In Oct
Brief: Astrazeneca Pharma India Gets Final Tax Assessment Order Of 140.8 Mln Rupees
Brief: Astrazeneca Pharma India June-Qtr Loss After Tax 117.9 Mln Rupees
Brief: Astrazeneca Pharma India Receives Permission For Voluntary Withdrawal Of Indication Of Olaparib (Lynparza)